The trial will study the use of hydroxychloroquine and azithromycin with or without tocilizumab and, among other objectives, whether these drugs reduce in-hospital mortality and the need for mechanical ventilation in the Intensive Care Unit.
https://www.isciii.es/Noticias/Noticias/Paginas/Noticias/PrimerosEnsayosFondoCOVID19.aspx
